Answers are grounded in this paper and cite their sources.
Shows changes in metabolism of CAR-T cells in melanoma, indicating metabolic adaptation during therapy.
Immunotherapy with the use of induced CAR-T cells is an effective method of cancer suppression in close to in vivo conditions. The question of the nature of metabolism of CAR-T cells in the conditions of fighting not against single cancer cells, but against tumor cells, remains relevant. Our studies have shown the metabolomic profile of mouse GD2-specific CAR-T cells upon contact with B78-21 melanoma tumor cells and upon exposure to B-21 melanoma 3D spheroid structures.
No takes yet. Share an insight, caveat, or question.
Bulygin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: